Publications | Page 119 | Pathology & Laboratory Medicine

Filter By Faculty

Filter by Principal Investigator

2020

Hayashi M, Guida E, Inokawa Y, Goldberg R, Reis LO, Ooki A, et al. GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma. Sci Signal. 2020;13(645).

Matrai C, Motanagh S, Mirabelli S, Ma L, He B, Chapman-Davis E, et al. Molecular Profiles of Mixed Endometrial Carcinoma. Am J Surg Pathol. 2020;44(8):1104-1111.

Satlin MJ, Westblade LF, Lee JR. Avoiding infections in transplant recipients: does the gut microbiota have a key role? Expert Rev Clin Immunol. 2020;16(2):113-115.

Kang Y, Marzuk PM, Safdieh JE, Falcone DJ, Choi AM. Weill Cornell Medicine. Acad Med. 2020;95(9S A Snapshot of Medical Student Education in the United States and Canada: Reports From 145 Schools):S371-S374.

Ruder B, Günther C, Stürzl M, Neurath MF, Cesarman E, Ballon G, et al. Viral FLIP blocks Caspase-8 driven apoptosis in the gut in vivo. PLoS One. 2020;15(1):e0228441.

Prabhu M, Cagino K, Matthews KC, Friedlander RL, Glynn SM, Kubiak JM, et al. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study. BJOG. 2020;127(12):1548-1556.

Skov R, Varga A, Matuschek E, Åhman J, Bemis D, Bengtsson B, et al. EUCAST disc diffusion criteria for the detection of mecA-Mediated β-lactam resistance in Staphylococcus pseudintermedius: oxacillin versus cefoxitin. Clin Microbiol Infect. 2020;26(1):122.e1-122.e6.

Mesa H, Manivel JC, Larson WS, Dachel SK, Reinink AR, Jessurun J. Immunophenotypic Comparison of Neoplasms of the Appendix, Right Colon, and Left Colon in Search of a Site-Specific Phenotypic Signature. Int J Surg Pathol. 2020;28(1):20-30.

Lu Y, Lin M, Zong J, Zong L, Zhao Z, Wang S, et al. Highly bioavailable curcumin preparation with a co-grinding and solvent-free process. Food Sci Nutr. 2020;8(12):6415-6425.

Witschen PM, Chaffee TS, Brady NJ, Huggins DN, Knutson TP, LaRue RS, et al. Erratum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. 2020, , 1325. Cancers (Basel). 2020;12(10).